3-135162160-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004441.5(EPHB1):c.1565G>A(p.Cys522Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000684 in 1,608,334 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004441.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EPHB1 | NM_004441.5 | c.1565G>A | p.Cys522Tyr | missense_variant | 7/16 | ENST00000398015.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EPHB1 | ENST00000398015.8 | c.1565G>A | p.Cys522Tyr | missense_variant | 7/16 | 1 | NM_004441.5 | P1 | |
ENST00000649588.1 | n.329-3832C>T | intron_variant, non_coding_transcript_variant | |||||||
EPHB1 | ENST00000647596.1 | c.1565G>A | p.Cys522Tyr | missense_variant | 7/16 | ||||
EPHB1 | ENST00000493838.1 | c.248G>A | p.Cys83Tyr | missense_variant | 5/14 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152182Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000618 AC: 9AN: 1456152Hom.: 0 Cov.: 30 AF XY: 0.00000829 AC XY: 6AN XY: 723894
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.1565G>A (p.C522Y) alteration is located in exon 7 (coding exon 7) of the EPHB1 gene. This alteration results from a G to A substitution at nucleotide position 1565, causing the cysteine (C) at amino acid position 522 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at